Convergence Investment Partners, LLC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 174 filers reported holding ACORDA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 2.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
Convergence Investment Partners, LLC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$219,000
-20.1%
16,473
-6.2%
0.05%
-23.8%
Q4 2018$274,000
-77.3%
17,568
-65.5%
0.06%
-59.9%
Q1 2018$1,206,000
+10.2%
50,9920.0%0.16%
+6.8%
Q4 2017$1,094,000
-15.5%
50,992
-6.8%
0.15%
-19.7%
Q3 2017$1,294,000
+151.8%
54,720
+171.8%
0.18%
+157.7%
Q2 2016$514,00020,1300.07%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,045,400$21,953,00012.28%
SCOPIA CAPITAL MANAGEMENT LP 5,568,306$116,934,0002.16%
GREAT POINT PARTNERS LLC 432,500$9,083,0001.80%
Consonance Capital Management LP 619,419$13,008,0001.36%
RA Capital Management 489,828$10,286,0001.26%
Ghost Tree Capital, LLC 300,000$6,300,0001.17%
DLD Asset Management, LP 281,900$5,920,0000.95%
DLD Asset Management, LP 281,900$5,914,0000.95%
Worth Venture Partners, LLC 36,650$770,0000.68%
Malaga Cove Capital, LLC 51,013$939,0000.57%
View complete list of ACORDA THERAPEUTICS INC shareholders